Leprosy Review – Policies and Procedures


1. Submission, peer review and acceptance of papers

All submissions to Leprosy Review should be made through our Submission site (see Instructions for Authors for full submission guidance).

Submissions are reviewed initially by the Editor-in-Chief; some that are deemed of little interest to the readership may be rejected at this stage. For shorter manuscripts, such as Editorials, Case reports, Letters or Short reports, the Editor will decide if an independent review is required.

Original papers, Review articles and Editorials with potential for publication will be reviewed by two independent reviewers. The Editor-in-Chief (or the appointed member of the Editorial board) reserves the right to select suitable reviewers although authors may suggest reviewers. Reviewers are other researchers/authors/experts who are considered suitable to evaluate the content of the article.

Once submitted, the reviewer comments are returned to the authors, with a decision from the Editor. The decision will be either to accept or reject the manuscript, or for a revision, based on the reviewers’ comments. Revised manuscripts will be assessed by the Editor and may be sent for further review before a final decision is made.

Editorials and review articles may be commissioned by the Editor or the Editorial Board, but will go through the same process of independent review as outlined above. Papers that are accepted will be edited for English and style prior to publication.

The journal operates a Single-Blind review process. This means that authors’ names, as they appear in the submitted manuscript, will be disclosed to the reviewer. But the identity of the reviewer will not be disclosed to the author. If the authors wish to conceal their name from reviewers they may submit their manuscript without author names – if they do, then they must upload a separate title page (marked “not for review”) with the full author details.

During the review process, and unless a decision of “Reject” has been made, authors may not submit their articles to another journal unless they withdraw their article from Leprosy Review – which they must confirm in writing to the Editor-in-Chief.

Submissions from the editorial board

Articles from the editorial board members are accepted for consideration by the journal. These articles will undergo the same reviewing process as a regular paper. The authors will not be involved in any of the review or decision process. 

Reviewer responsibilities

Reviewers are invited on the understanding that they will treat all communications from the journal, and any article which they see, as confidential, and will not discuss the article with anyone apart from the inviting editor, and will not use the contents of the article within their research until (and only if) the article is published. If a reviewer considers that they have a conflict of interest that may affect their review of an article they should disclose this to the editor before they submit the review, and they may be excused the duty of reviewing.

Please refer to the COPE guidelines on the responsibilities of Reviewers: https://publicationethics.org/resources/guidelines-new/cope-ethical-guidelines-peer-reviewers

If a reviewer wishes a colleague to review the article in their place, they must inform the inviting editor, so that the correct attribution is given to the review.

Reviewers are acknowledged and thanked in the final issue of each year (without disclosing which article they reviewed).

Authorship and contributorship

All persons identified as authors must have made a substantial contribution to the conception or design of the work being reported, including the acquisition, analysis, and/or interpretation of data for the work; and have participated in the drafting the work or revising it critically for important intellectual content; and must have approved the final version submitted, and finally published. This follows the authorship criteria as outlined by the ICMJE.

Anybody not fulfilling these criteria but contributing to the article should be named as a contributor in the Acknowledgements section.

We require all articles to list all authors and contributors at the end of the article, indicating their contribution – e.g. “PS designed the survey, LC analysed the data”. The name of a guarantor should also be provided.

The guarantor accepts full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish. Leprosy Review will expect foreign authors to have national collaborators. We do not publish studies that involve fieldwork, personnel and infrastructure abroad, but fail to involve local authors.

Data sharing

Leprosy Review encourages authors to make their research data freely available. This means either:

  1. Uploading the data set to a suitable repository (see below), or
  2. Adding it to the article as an appendix, or
  3. Making it available on request from readers.

Small data sets (e.g. Excel files, survey data) can be added to the article as an appendix, but we encourage authors to upload their data sets to suitable repositories (see below) as the best solution.

Please note that all data sets must be fully anonymised before making them public so that no personal details of patients are available or may be inferred from the data.

We ask all authors to add a data availability statement within the article, for example:

The supporting data for this article is available at {name of repository}, {link to the DOI or URL of the data set}, {reference number if applied].


The supporting data for this article can be obtained from the corresponding author on request.


The supporting data for this article were derived from the following sources: {citation including link}


The supporting data for this article is not available. 

Example data repositories:

Dryad - http://datadryad.org 

Figshare - https://figshare.com 

Mendeley Data - https://data.mendeley.com 

Zenodo - https://zenodo.org 

Code Ocean - https://codeocean.com

Or the author’s own institutional (not personal) repository 

Preprinting and repositories

We are happy to accept articles that have already been posted in a preprint or institutional repository. We strongly encourage authors to link the repository or preprint version to the final published version (if the article is accepted). Please note that such posting should be declared to the editor on submission.

2. Ethical Guidelines

Leprosy Review adheres to the editing and publishing standards recommended by the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE)




We require all authors to adhere to internationally accepted ethical standards of research and publication. We expect all research to adhere to the World Medical Association's Declaration of Helsinki

Review Board approval

All submissions to Leprosy Review must include a statement in the body of the article concerning ethical approval of the study and, if relevant, the ethical care of animals involved in the study. The statement must indicate approval by a named Institutional Review Board (IRB) or an equivalent body, or the authors must present the reasons why formal approval was not required.

Disclosure of conflict of interest

Each author and reviewer must list any potential conflict of interest, both financial and non-financial, which could be seen to influence the role they may play in the publication of the paper. If there are no competing interests to declare, authors should include a statement to that effect (e.g. “The authors report no conflicts of interest”). This must be included in the body of the article.

All members of the editorial board and reviewers are also required to declare any conflict of interest when considering submitted articles. These may include, for example, competing research, or recent collaboration with the authors. 

Funding information

All papers supported by a funding body or grant must include details in the following format:

  • Single agency grants: This work was supported by the [Funding Agency] under Grant [number x].
  • Multiple agency grants: This work was supported by the [funding Agency 1]; under Grant [number x]; [Funding Agency 2] under Grant [number x]; and [Funding Agency 3] under Grant [number x].

For all NIH or Wellcome-funded papers, the grant number(s) must be included.

This information must be included in the body of the article.

Patient consent

Authors must have obtained and be able to provide evidence of appropriate written consents, permissions, and releases for all individuals involved in the research. Permissions should cover case details, personal information, and images of patients.

Where patient identities may be revealed within an article (e.g. a photograph) a statement confirming the obtained consent must be included within the article. The journal reserves the rights to request a copy of these permissions if it wishes.

Clinical Trials Registry

In accordance with the ICMJE guidelines, any papers involving clinical trials should provide trial registration numbers in the abstract, and full details in the methods section.

A list of registries that meet ICMJE requirements can be found at the WHO International Clinical Trials Registry Platform (ICTRP). 

Clinical trials should adhere to CONSORT guidelines. 

Systematic reviews and meta-analysis should adhere to PRISMA guidelines.

3. Misconduct and corrections

Where an error or other problem with a published article is identified by, or reported to, the Editor-in-Chief in writing, the editor and publisher will jointly decide on the best means of correction, following COPE guidelines and taking advice from the Editorial Board or other external body as required. The Editor will communicate with the authors, and Errata, retractions, and corrections may be published. The Editor’s decision is final.

Where serious fraud is detected, the Editors and the publisher reserve the right to speak to the author’s institution.

During submission articles may be checked for duplication/plagiarism. If evidence of plagiarism is detected this will lead to immediate rejection.

4. Appeals

Where an author disagrees with the editor’s decision to reject an article, they may appeal the decision. Appeals must be submitted in writing (e-mail), giving clear reasons why the author(s) considers the reason incorrect. The Editor-in-Chief will consult with one or more of the editorial board and may send the article out for further review. Authors may only appeal once, and the Editor-in-Chief’s decision is final.

5. Ownership, funding and Editorial independence

The journal was founded by Lepra in 1928 who are the owners and publishers. Lepra is a UK-based international charity working to beat leprosy (https://www.lepra.org.uk).

Leprosy Review is funded by grants from Lepra and members of ILEP – the International Federation of Anti-Leprosy Associations. The journal is editorially independent of Lepra and ILEP. Publishing decisions are made by the Editor and Editorial board independent of Lepra or ILEP contributing agencies.


There are no submission or publication fees.

6. Disclaimer

The views expressed in the journal represent those of the respective authors, and do not necessarily reflect those of the editors, Lepra or ILEP. Similarly, mention of any therapies or commercial products does not imply endorsement by Lepra, ILEP or the editors.